Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALA-PROS: Preoperative 5-aminolevulinic acid for margin visualization in robot-assisted radical prostatectomy
jRCTs031250607Recruiting
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of 5-aminolevulinic acid in prostate cancer (PCa). Primary endpoint: Sensitivity of fluorescence for positive surgical margins. Started Dec 2025; status: recruiting.
02
Drugs
5-aminolevulinic acid
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on jRCTs031250607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031250607.